Instruction for use: ErvevaxI want this, give me price
Dosage form: Lyophilizate for the preparation of solution
Active substance: Vaccinum ad prophylaxim rubeollae vivum
J07BJ01 Rubella live weakened virus
Vaccines, serums, phages and toxoids
Nosological classification (ICD-10)
Z24.5 The need for immunization against rubella alone
Composition and release form
1 vaccination dose of vaccine contains vaccine strain Wistar RA 27/3 rubella virus not less than 1000 TCID50, neomycin B sulfate not more than 25 μg; In vials of 1 or 10 doses, complete with a solvent in ampoules (water for injection); In a box of 100 or 50 bottles, or in a vial 1 dose, complete with a solvent in the ampoule (water for injection) and a syringe, in the box 1 set.
White with a slightly pinkish hue, the lyophilized powder compressed into a tablet (in the solution has a color from light orange to light red) is a preparation of a highly attenuated strain Wistar RA 27/3 of the rubella virus, cultivated in human diploid cells.
Mode of action - Immunostimulating.
Dosing and Administration
For vaccination of children 12-15 months and 6 years (according to the national calendar), as well as adolescent girls and women of childbearing age outside of pregnancy. SC, it is supposed IM, on 0,5 ml. Before injection, the powder is dissolved with the applied solvent - water for injection.
Storage conditions of the drug Ervevax
In the refrigerator, at a temperature of 2-8 ° C. Solvent - at a temperature of 2-25 ° C.
Keep out of the reach of children.
The shelf life of the drug Ervevax
Do not use beyond the expiration date printed on the package.